Views and reviews
Assessing the true incidence of mosaicism in preimplantation embryos

https://doi.org/10.1016/j.fertnstert.2017.03.019Get rights and content
Under an Elsevier user license
open archive

Modern technologies applied to the field of preimplantation genetic diagnosis for aneuploidy screening (PGD-A) have improved the ability to identify the presence of mosaicism. Consequently, new questions can now be addressed regarding the potential impact of embryo mosaicism on diagnosis accuracy and the feasibility of considering mosaic embryos for transfer. The frequency of chromosomal mosaicism in products of conception (POCs) of early miscarriages has been reported to be low. Mosaic embryos with an aneuploid inner cell mass are typically lost during the first trimester owing to spontaneous miscarriages. Most of the mosaics in established pregnancies would derive from placental mosaicism or placental aneuploidy, and mosaic embryos with aneuploid inner cell mass should be lost mainly due to first-trimester spontaneous miscarriages. The well described clinical outcomes of live births from mosaic embryos suggest a wide spectrum of phenotypes, from healthy to severely impaired. Therefore, there is a need to balance the risks of discarding a possibly viable embryo with that of transferring an embryo that may ultimately have a lower implantation potential.

Key Words

Mosaicism
aneuploidy
blastocyst
embryo
preimplantation genetic diagnosis

Cited by (0)

M.V.-R. has nothing to disclose. C.R. has nothing to disclose.

M.V.-R. and C.R. should be considered similar in author order.